Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
KNSA: Kiniksa Pharmaceuticals International, plc Stock Analysis | finqOS
Healthcare · Medical - Pharmaceuticals
The Story
KNSA
The Story
KNSA
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Operating margin
11.9%
ROIC
9.7%
Financially safe
Stretched
Debt / equity
0.01×
Interest coverage
0.0×
Current ratio
3.90×
Valuation
Unrated
P/E ratio
69.5×
Kiniksa Pharmaceuticals International, plc
KNSA
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Kiniksa Pharmaceuticals International, plc
KNSA
NASDAQ
·
USD
·
Closed
$74.34
−4.94%
$74.34
−$3.86 (4.94%)
52W Range
84th
pctl
Volume
1.32×
avg
Mkt Cap
5.67B
USD
P/E
69.5
TTM
Div Yield
–
ann
52W Range
84th
pctl
Volume
1.32×
avg
Market Cap
5.67B
USD
P/E Ratio
69.5
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings